Sulochana Bhandarkar is a Dermatology physician. OpenAlex indexes 17 publications with 704 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
425 University Blvd
Round Rock, TX 786651047
Telephone
512-509-0200Provider last certified this registry record 6 Dec 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- KYOWA KIRIN, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
38%Corticosteroid21.1%Triamcinolone Acetonide90%Fluocinolone Acetonide10%Part D≥93 patientsVitamin D Analog9.8%Calcipotriene100%Part D≥66 patients+ 3 more classes in this area
Sensory organs
19.9%Corticosteroid19.9%Clobetasol Propionate51%Hydrocortisone49%Part D≥45 patientsAnti-infectives
17.9%Azole Antifungal8.9%Ketoconazole66%Fluconazole34%Part D<11 patientsLincosamide Antibacterial4.2%Clindamycin Phosphate100%Part D≥11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tuberculosis verrucosa cutis lesions exhibit a greater microvessel count than lupus vulgaris lesions
Experimental Dermatology
2016 - Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
Journal of Clinical Investigation
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”